Asia-Pacific Cell Counting Market to Hit $899.7 Million by 2035 with Biotech & Pharma Growth

Asia-Pacific cell counting market was valued at $470.8 million in 2025 and is projected to reach $899.7 million by 2035, growing at a CAGR of 6.8% during the forecast period (2026–2035). The growth of biotechnology and pharmaceutical research and development in the Asia-Pacific region is significantly influencing the demand for cell counting solutions. Countries such as China, India, Japan, and South Korea are expanding their R&D capabilities, driven by increasing investment in drug discovery, development, and clinical research. Accurate and efficient cell counting is critical for applications ranging from quality control to experimental reproducibility in laboratory workflows. As pharmaceutical and biotech organizations scale their operations, the adoption of advanced cell counting technologies supports high-throughput analysis and data reliability. This trend reflects the broader modernization of laboratory infrastructure and the region’s focus on enhancing research productivity and innovation.

Browse the full report description of “Asia-Pacific Cell Counting Market Size, Share & Trends Analysis Report by Product Type (Instruments and Consumables), By Application (Medical Applications, Research, and Industrial), By End-User (Pharmaceuticals & Biotechnology Companies, Research Institutes & CRO, and Hospitals and Diagnostic Laboratories), Forecast Period 2026-2035” of https://www.omrglobal.com/industry-reports/asia-pacific-cell-counting-market

Major nations in Asia have seen growing investment in the biotechnology sector, with India emerging as a key destination. In July 2023, 15 companies signed memorandums of understanding worth $240 million to support biotech initiatives. India ranks among the top 12 biotechnology destinations globally and is the third-largest market in the Asia-Pacific region, contributing around 3% of the global biotech market. The Department of Biotechnology (DBT), under the Ministry of Science and Technology, has been instrumental in developing a strong ecosystem for research, innovation, and commercialization across biopharmaceuticals, bio-services, bio-agriculture, bio-industrial, and bio-IT sectors.

 High-Content Imaging and Automated Flow Cytometry Lead Market Growth

The major companies operating in the Asia-Pacific cell counting market include Abbott Laboratories, Beckman Coulter, Inc., Becton, Dickinson and Company, Sysmex Corp, and Thermo Fisher Scientific Inc., among others. These companies are advancing cell counting technologies with innovations in high-content imaging and automated flow cytometry. These developments enhance accuracy, speed, and standardization for research and clinical applications across the Asia-Pacific region

• In September 2024, Hamamatsu Photonics launched the CYTOQUBE Light-Sheet Microplate Cytometer (C15200-01RGBU), a new class of cell analyzer designed for advanced live cell imaging. The system uses light-sheet microscopy combined with the Zyncscan® image processing platform to rapidly acquire 3D fluorescence images of multiwell plates. It enables fast, high-content analysis of cell size, shape, number, and fluorescence intensity, while improving signal-to-noise ratios by reducing background fluorescence. 

• In May 2023, Sysmex Corp. launched the Flow Cytometer XF-1600, Sample Preparation System PS-10, and related antibody reagents in Japan, following earlier introductions in North America, Europe, and the Asia-Pacific region. The expanded clinical flow cytometry portfolio enabled automation from sample preparation through result reporting, supporting standardized and efficient testing for hematological disease diagnosis.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product Type
  • By Application
  • By End-User
• Competitive Landscape - Abbott Laboratories, Beckman Coulter, Inc., Becton, Dickinson and Company, Sysmex Corp, and Thermo Fisher Scientific Inc., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Asia-Pacific Cell Counting Market Report Segment

By Product Type

• Instruments
• Consumables

By Application

• Medical Applications
• Research

By End-User

• Pharmaceuticals and Biotechnology Companies
• Research Institutes and CRO
• Hospitals and Diagnostic Laboratories

Asia-Pacific Cell Counting Market Report Segment by Region

• China
• Japan
• South Korea
• India
• Australia & New Zealand
• ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
• Rest of Asia-Pacific

 To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-cell-counting-market